AI Rally Concerns Spark Market Volatility as DeepSeek Plans $70 Billion Funding

Global markets are experiencing a downturn in AI-related stocks, with Japan's Nikkei 225 index plummeting over 10% from its June 25 peak due to concerns about the global AI rally. The decline is attributed to fears about the sustainability of the AI-driven market surge.

Despite the market volatility, several AI-focused companies and startups are making significant strides. Ditto Bio, for instance, is leveraging AI to develop autoimmune drug candidates, targeting a $120 billion annual market. Meanwhile, Chinese AI companies are reporting substantial profit gains, with some stocks soaring over 1000%.

DeepSeek, a Chinese AI firm, is planning a new funding round at a $70 billion valuation, backed by tech giants like Tencent and JD.com. This valuation is a testament to the growing confidence in AI technology and its potential for future growth.

Tech giants like Amazon, Google, and Meta are also investing heavily in AI infrastructure and products. Amazon's new AI-powered staffing system initially caused issues but has since been resolved. Alphabet, Google's parent company, has seen its stock rise 11% this year but is now facing concerns about its AI products.

Other notable developments include Creatio 10x's launch of no-code AI agents and enterprise governance tools, South Korea's efforts to build a sovereign AI model for cybersecurity, and the transformative impact of AI on global cancer care through precision radiotherapy and adaptive treatment.

Key Takeaways

['Ditto Bio is using AI to develop autoimmune drug candidates targeting a $120 billion annual market.', 'DeepSeek plans a new funding round at a $70 billion valuation.', "Japan's Nikkei 225 index has plummeted over 10% from its June 25 peak due to AI rally concerns.", 'Chinese AI companies report huge profit surges, with some stocks soaring over 1000%.', "Amazon's AI-powered staffing system initially caused issues but has since been resolved.", 'Alphabet stock has risen 11% this year but faces concerns about its AI products.', 'Creatio 10x launches no-code AI agents and enterprise governance tools.', 'South Korea builds a sovereign AI model for cybersecurity.', 'AI transforms global cancer care through precision radiotherapy and adaptive treatment.', 'Meta, ASML, and TSMC are investing heavily in AI infrastructure.']

Japan Stocks Plummet as AI Rally Concerns Grow

Japan's Nikkei 225 Stock Average dropped over 10% from its June 25 peak due to concerns about the global AI rally. The index fell 4% to 64,141.12, marking its worst weekly loss since April 2025. The broader Topix index also declined 2.7% to 3,919.21.

AI Stocks Fall as Oil Prices Climb

AI stocks continue to decline while oil prices keep rising. The trend is causing concerns among investors. Japan's Nikkei 225 index and other global markets are affected.

Ditto Bio Uses AI to Fight Autoimmune Diseases

Ditto Bio is using AI to mine proteins from parasites, viruses, and ticks to create autoimmune drug candidates. The startup aims to tackle the $120B+ annual drug market for autoimmune diseases affecting 50 million Americans.

China's AI Stocks Soar with 1000%-Plus Profit Gains

China's AI companies report huge profit surges, but investors are cautious due to high expectations. The stocks have rallied in recent months, and earnings growth is expected to continue.

DeepSeek Seeks New Funding at $70 Billion Valuation

Chinese AI firm DeepSeek plans a new funding round after its $7 billion Series A round in June. The company aims to reach a $70 billion valuation and is backed by tech giants like Tencent and JD.com.

Amazon's AI Staffing System Causes Initial Issues

Amazon's new AI-powered staffing system caused problems on facility floors, prompting a manager to request a shutdown. However, the company says it has resolved the issues and the system is now running smoothly.

Alphabet Stock Hit by AI Fears

Alphabet stock has risen 11% this year but is now facing concerns about its AI products and those of Chinese rivals. The company is working to address these fears and stay competitive.

AI Infrastructure Investment Continues to Grow

Companies like ASML, TSMC, and Meta are investing heavily in AI infrastructure, including semiconductor manufacturing and data centers. The investments are expected to drive growth in the AI sector.

Creatio 10x Launches No-Code AI Agents

Creatio 10x introduces no-code AI agents and enterprise governance tools to make AI development accessible across the enterprise. The platform aims to help businesses automate sales, marketing, and customer service.

South Korea Builds Sovereign AI Model for Cybersecurity

South Korea is developing a sovereign AI model for cybersecurity to reduce reliance on foreign providers. The model aims to protect critical infrastructure from AI-powered cyber threats.

AI Transforms Global Cancer Care

Artificial intelligence is transforming cancer care through precision radiotherapy, adaptive treatment, and automation. The technology is improving patient outcomes and streamlining clinical workflows.

Sources

NOTE:

This news brief was generated using AI technology (including, but not limited to, Google Gemini API, Llama, Grok, and Mistral) from aggregated news articles, with minimal to no human editing/review. It is provided for informational purposes only and may contain inaccuracies or biases. This is not financial, investment, or professional advice. If you have any questions or concerns, please verify all information with the linked original articles in the Sources section below.

AI Stocks Nikkei 225 Topix Oil Prices Investors Ditto Bio Autoimmune Diseases China Profit Gains Earnings Growth DeepSeek Funding Round Tencent JD.com Amazon AI Staffing System Alphabet AI Products Chinese Rivals AI Infrastructure ASML TSMC Meta Semiconductor Manufacturing Data Centers Creatio 10x No-Code AI Agents Enterprise Governance South Korea Sovereign AI Model Cybersecurity Foreign Providers AI-Powered Cyber Threats Global Cancer Care Precision Radiotherapy Adaptive Treatment Automation Patient Outcomes Clinical Workflows

Comments

Loading...